Characterization of a PA14 domain-containing galactofuranose-specific β-d-galactofuranosidase from Streptomyces sp. 2017

Emiko Matsunaga, and Yujiro Higuchi, and Kazuki Mori, and Nao Yairo, and Saki Toyota, and Takuji Oka, and Kosuke Tashiro, and Kaoru Takegawa
a Faculty of Agriculture, Department of Bioscience and Biotechnology , Kyushu University , Fukuoka , Japan.

As a constituent of polysaccharides and glycoconjugates, β-d-galactofuranose (Galf) exists in several pathogenic microorganisms. Although we recently identified a β-d-galactofuranosidase (Galf-ase) gene, ORF1110, in the Streptomyces strain JHA19, very little is known about the Galf-ase gene. Here, we characterized a strain, named JHA26, in the culture supernatant of which exhibited Galf-ase activity for 4-nitrophenyl β-d-galactofuranoside (pNP-β-d-Galf) as a substrate. Draft genome sequencing of the JHA26 strain revealed a putative gene, termed ORF0643, that encodes Galf-ase containing a PA14 domain, which is thought to function in substrate recognition. The recombinant protein expressed in Escherichia coli showed the Galf-specific Galf-ase activity and also released galactose residue of the polysaccharide galactomannan prepared from Aspergillus fumigatus, suggesting that this enzyme is an exo-type Galf-ase. BLAST searches using the amino acid sequences of ORF0643 and ORF1110 Galf-ases revealed two types of Galf-ases in Actinobacteria, suggesting that Galf-specific Galf-ases may exhibit discrete substrate specificities.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008351 Mannans Polysaccharides consisting of mannose units. Mannan
D010802 Phylogeny The relationships of groups of organisms as reflected by their genetic makeup. Community Phylogenetics,Molecular Phylogenetics,Phylogenetic Analyses,Phylogenetic Analysis,Phylogenetic Clustering,Phylogenetic Comparative Analysis,Phylogenetic Comparative Methods,Phylogenetic Distance,Phylogenetic Generalized Least Squares,Phylogenetic Groups,Phylogenetic Incongruence,Phylogenetic Inference,Phylogenetic Networks,Phylogenetic Reconstruction,Phylogenetic Relatedness,Phylogenetic Relationships,Phylogenetic Signal,Phylogenetic Structure,Phylogenetic Tree,Phylogenetic Trees,Phylogenomics,Analyse, Phylogenetic,Analysis, Phylogenetic,Analysis, Phylogenetic Comparative,Clustering, Phylogenetic,Community Phylogenetic,Comparative Analysis, Phylogenetic,Comparative Method, Phylogenetic,Distance, Phylogenetic,Group, Phylogenetic,Incongruence, Phylogenetic,Inference, Phylogenetic,Method, Phylogenetic Comparative,Molecular Phylogenetic,Network, Phylogenetic,Phylogenetic Analyse,Phylogenetic Clusterings,Phylogenetic Comparative Analyses,Phylogenetic Comparative Method,Phylogenetic Distances,Phylogenetic Group,Phylogenetic Incongruences,Phylogenetic Inferences,Phylogenetic Network,Phylogenetic Reconstructions,Phylogenetic Relatednesses,Phylogenetic Relationship,Phylogenetic Signals,Phylogenetic Structures,Phylogenetic, Community,Phylogenetic, Molecular,Phylogenies,Phylogenomic,Reconstruction, Phylogenetic,Relatedness, Phylogenetic,Relationship, Phylogenetic,Signal, Phylogenetic,Structure, Phylogenetic,Tree, Phylogenetic
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D003001 Cloning, Molecular The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells. Molecular Cloning
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D005690 Galactose An aldohexose that occurs naturally in the D-form in lactose, cerebrosides, gangliosides, and mucoproteins. Deficiency of galactosyl-1-phosphate uridyltransferase (GALACTOSE-1-PHOSPHATE URIDYL-TRANSFERASE DEFICIENCY DISEASE) causes an error in galactose metabolism called GALACTOSEMIA, resulting in elevations of galactose in the blood. D-Galactose,Galactopyranose,Galactopyranoside,D Galactose
D005697 Galactosides Glycosides formed by the reaction of the hydroxyl group on the anomeric carbon atom of galactose with an alcohol to form an acetal. They include both alpha- and beta-galactosides.
D006026 Glycoside Hydrolases Any member of the class of enzymes that catalyze the cleavage of the glycosidic linkage of glycosides and the addition of water to the resulting molecules. Endoglycosidase,Exoglycosidase,Glycohydrolase,Glycosidase,Glycosidases,Glycoside Hydrolase,Endoglycosidases,Exoglycosidases,Glycohydrolases,Hydrolase, Glycoside,Hydrolases, Glycoside
D000072417 Protein Domains Discrete protein structural units that may fold independently of the rest of the protein and have their own functions. Peptide Domain,Protein Domain,Domain, Peptide,Domain, Protein,Domains, Peptide,Domains, Protein,Peptide Domains

Related Publications

Emiko Matsunaga, and Yujiro Higuchi, and Kazuki Mori, and Nao Yairo, and Saki Toyota, and Takuji Oka, and Kosuke Tashiro, and Kaoru Takegawa
July 2019, Carbohydrate research,
Emiko Matsunaga, and Yujiro Higuchi, and Kazuki Mori, and Nao Yairo, and Saki Toyota, and Takuji Oka, and Kosuke Tashiro, and Kaoru Takegawa
June 2013, Bioorganic & medicinal chemistry,
Emiko Matsunaga, and Yujiro Higuchi, and Kazuki Mori, and Nao Yairo, and Saki Toyota, and Takuji Oka, and Kosuke Tashiro, and Kaoru Takegawa
March 2023, Enzyme and microbial technology,
Emiko Matsunaga, and Yujiro Higuchi, and Kazuki Mori, and Nao Yairo, and Saki Toyota, and Takuji Oka, and Kosuke Tashiro, and Kaoru Takegawa
September 2021, Bioorganic & medicinal chemistry letters,
Emiko Matsunaga, and Yujiro Higuchi, and Kazuki Mori, and Nao Yairo, and Saki Toyota, and Takuji Oka, and Kosuke Tashiro, and Kaoru Takegawa
October 1995, Bioscience, biotechnology, and biochemistry,
Emiko Matsunaga, and Yujiro Higuchi, and Kazuki Mori, and Nao Yairo, and Saki Toyota, and Takuji Oka, and Kosuke Tashiro, and Kaoru Takegawa
August 2011, Enzyme and microbial technology,
Emiko Matsunaga, and Yujiro Higuchi, and Kazuki Mori, and Nao Yairo, and Saki Toyota, and Takuji Oka, and Kosuke Tashiro, and Kaoru Takegawa
May 2019, International journal of biological macromolecules,
Emiko Matsunaga, and Yujiro Higuchi, and Kazuki Mori, and Nao Yairo, and Saki Toyota, and Takuji Oka, and Kosuke Tashiro, and Kaoru Takegawa
May 2018, Enzyme and microbial technology,
Emiko Matsunaga, and Yujiro Higuchi, and Kazuki Mori, and Nao Yairo, and Saki Toyota, and Takuji Oka, and Kosuke Tashiro, and Kaoru Takegawa
July 1996, Bioscience, biotechnology, and biochemistry,
Emiko Matsunaga, and Yujiro Higuchi, and Kazuki Mori, and Nao Yairo, and Saki Toyota, and Takuji Oka, and Kosuke Tashiro, and Kaoru Takegawa
April 2009, Bioorganic & medicinal chemistry,
Copied contents to your clipboard!